Doctor Sinemis Celik
7
reviews
12/07/2022
12/01/2021
15/07/2024
22/03/2023
08/11/2024
05/06/2023
19/02/2024
Sinemis Celik is a Turkish medical oncologist currently practicing at Medical Park Istanbul Oncology Hospital (Maltepe district, Istanbul). She specializes in systemic drug therapy for adult cancer patients, with a primary focus on breast cancer, lung cancer, colorectal cancer, and prostate cancer.
She received her medical degree from the Pamukkale University Faculty of Medicine. From 2005 to 2011, she completed her residency in Internal Medicine at the Department of Internal Medicine, Pamukkale University. After completing her residency in 2011, she fulfilled her mandatory government service as an Internal Medicine specialist at Hakkari State Hospital (Hakkari Devlet Hastanesi).
From 2011 to 2014, she underwent subspecialty training (Sub-specialty Fellow) in Medical Oncology at Dr. Lütfi Kırdar Kartal Training and Research Hospital in Istanbul. Between 2014 and 2017, she worked as a Medical Oncologist at Sultan I Murat State Hospital in Edirne. From 2017 to 2019, she served as an Assistant Professor (Dr. Öğr. Üyesi) at Okan University Hospital in Istanbul, where she was also a member of the academic education committee. She later joined Medical Park Istanbul Oncology Hospital, where she currently practices.
In her clinical work, she applies modern standards of systemic treatment for solid tumors, including chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. She has participated in international multicenter clinical trials, including projects related to the Turkish oncology registry for metastatic colorectal cancer.
She is a co-author of scientific publications in international peer-reviewed journals, including Tumour Biology, Clinical and Translational Oncology, and the Journal of Oncology Pharmacy Practice. Her research interests include breast cancer treatment, metastatic colorectal cancer, lung cancer, and the molecular biology of prostate cancer.
She is a member of the Turkish Society of Medical Oncology (Türk Tıbbi Onkoloji Derneği), the European Society for Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO).
She consults patients in Turkish and English.
Achievements and awards of Doctor Sinemis Celik
About Doctor Sinemis Celik
- Breast cancer treatment
- Lung cancer treatment
- Colorectal cancer treatment
- Prostate cancer treatment
- Systemic chemotherapy for solid tumors
- Targeted therapy
- Immunotherapy in oncology
- Hormonal therapy
- Pamukkale University Faculty of Medicine, Denizli, Turkey
- 2005–2011 — Residency in Internal Medicine, Department of Internal Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey
- 2011–2014 — Subspecialty training in Medical Oncology (Sub-specialty Fellow), Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
Dr. Sinemis Celik specializes in medical oncology and systemic drug therapy for cancer. Throughout her career, she has worked in both public and university hospitals in Turkey and is currently practicing at Medical Park Oncology Hospital (Istanbul).
- Hakkari State Hospital (Hakkari, Turkey) — 2011, Internal Medicine Specialist, mandatory government service following residency in internal medicine
- Sultan I Murat State Hospital (Edirne, Turkey) — 2014–2017, Medical Oncologist
- Okan University Hospital (Istanbul, Turkey) — 2017–2019, Medical Oncologist, Associate Professor (Assistant Professor), member of the departmental education committee
- Medical Park Oncology Hospital (Istanbul, Maltepe district, Turkey) — present, Medical Oncologist
Dr. Sinemis Celik is a co-author of scientific publications in international peer-reviewed journals. Her research interests include breast cancer treatment, metastatic colorectal cancer, lung cancer, molecular biology and treatment of prostate cancer, as well as real-world clinical applications of immunotherapy in solid tumors.
Main research interests:
- Breast cancer treatment
- Metastatic colorectal cancer
- Lung cancer
- Molecular biology and treatment of prostate cancer
- Real-world data on immunotherapy use in metastatic urothelial carcinoma
Selected publications:
- Tumour Biology — co-author of a publication in an international journal of the International Society of Oncology and BioMarkers Development
- Clinical and Translational Oncology, 2016, Vol. 18(6) — co-author
- Türkiye Klinikleri, 2017 — co-author of a review publication on molecular biology and treatment of prostate cancer
- Journal of Oncology Pharmacy Practice, 2025, Vol. 31(3): 404–411 — co-author of the Onco-colon Turkey registry study on real-world treatment of metastatic colorectal cancer
- Future Oncology, 2025, Vol. 21(27): 3499–3505 — co-author of a study on maintenance therapy with avelumab in patients with metastatic urothelial carcinoma within an expanded access program
- Turkish Society of Medical Oncology (Türk Tıbbi Onkoloji Derneği)
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
Medical Park Istanbul Oncology Hospital is a specialized oncology center located in the Maltepe district of Istanbul. It is part of MLP Care, one of the largest private healthcare groups in Turkey.
The hospital provides a full range of cancer diagnostics and treatment, including medical oncology, radiation therapy, surgical oncology, and supportive care. Its multidisciplinary team includes experienced oncologists, radiologists, and medical imaging specialists.
The hospital treats both locally insured patients and international patients, including those traveling from abroad for medical care.
